Ask Our Experts - Intertek Pharmaceutical Services

Mark Parry, Technical Director
Mark has nearly 20 years’ experience working within the pharmaceutical analysis and formulation development industry, with a particular focus on OINDPs. Mostly working in the pre-approval stages, Mark’s background includes extensive experience with product and formulation development for novel and generic products, as well as method development and validation, stability studies, pharmaceutical development activities, and clinical trial manufacturing for a wide range of clients.

ASK A QUESTION NOW

Ashleigh Wake, Business Development Director
Ashleigh has held technical and operational management roles in Zeneca, AstraZeneca and Syngenta before joining Intertek. She has a 20 year career as an operational / technical team leader and study director and has specialized in the delivery of GXP studies on biopharma structure, physiochemical and biological activity. She is currently responsible for strategic growth and business development at Intertek’ centre of excellence for biologics characterisation in the UK.

ASK A QUESTION NOW

Full Biography

 

John Todd, Business Development Director
John has held commercial and management roles in several technology companies. He joined Intertek in 2015 and has been responsible for business development, account management, and stewardship of new and existing partnerships. He routinely works with global companies to design tailored outsourcing contracts to meet their technical and commercial needs and has presented at conferences on outsourcing models for the biopharma sector.

ASK A QUESTION NOW